Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Phosphoinositide 3-kinase gamma peptide

EU orphan designation number: EU/3/17/1859   
Active ingredient: Phosphoinositide 3-kinase gamma peptide
Indication: Treatment of cystic fibrosis
Sponsor: Kither Biotech s.r.l.
Via Nizza 52, 10126 Torino, Italia

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2017 Orphan designation EMA/OD/303/16 (2017)1987 of 20/03/2017